BACKGROUND: From 1991 through 1996, nine transfusion-related cases of septi
cemia and endotoxemia occurred in New Zealand, a rate approximately 80 time
s that in the United States. Eight cases involved the transfusion of Yersin
ia enterocolitica-infected blood and one involved Serratia liquefaciens-inf
ected blood. Six of the recipients died. Donor exclusion by recent gastroin
testinal illness failed to prevent the four most recent such infections, an
d it has led to an estimated 3- to 5-percent rate of donor def ferral.
STUDY DESIGN AND METHODS: An antigen preparation containing the released pr
oteins (Yops) of Y. enterocolitica was used to establish an EIA to detect I
gA directed against these proteins in donated blood. The assay was tested w
ith serum from donors in transfusion-related endotoxemia cases, subjects wh
o were stool culture-positive for Y enterocolitica, and 495 healthy volunte
er blood donors.
RESULTS: The assay detected anti-Yop IgA in the donors of all 6 infected un
its tested. Ninety-six percent of culture-positive subjects tested positive
, whereas there was 70-percent positivity with a commercial immunoassay bas
ed on lipopolysaccharide, Five percent of random donors tested positive; on
ly one of these had Y enterocolitica present in a stool sample, and none we
re bacteremic.
CONCLUSION: The anti-Yop immunoassay used in this study could be applied to
reduce the risk of posttransfusion endotoxic shock caused by Y enterocolit
ica.